The universal hepatitis B birth dose must be protected.
NASPGHAN Urges ACIP to Maintain the Universal Hepatitis B Birth-Dose Recommendation The universal hepatitis B birth-dose vaccination remains a critical, evidence-based public health measure that protects newborns from hepatitis B virus (HBV) infection and its long-term consequences. Maintaining this recommendation is essential to ensuring consistent, equitable protection for all infants across the United States. NASPGHAN
read more



